VRM
CLX icon

Vectors Research Management’s Clorox CLX Stock Holding History

Vectors Research Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60
Closed -$10K – 489
2021
Q4 		$10K Hold
60
– – ﹤0.01% 416
2021
Q3 		$10K Hold
60
– – ﹤0.01% 362
2021
Q2 		$11K Buy
+60
New +$11K ﹤0.01% 375

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vectors Research Management's CLX Position: Q1 2022 in Review

Vectors Research Management sold out of Clorox (CLX) in Q1 2022, closing a stake of 60 shares — an estimated $10K sold.

Vectors Research Management first reported a position in CLX in Q2 2021 and held it in 3 quarters. The position peaked at $11K in Q2 2021. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Vectors Research Management reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Vectors Research Management sold 60 Clorox shares in Q1 2022, an estimated $10K.
  • Vectors Research Management first reported a position in Clorox in Q2 2021 and held it in 3 quarters.
  • Vectors Research Management's Clorox position peaked at $11K in Q2 2021.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Vectors Research Management's 13F filing for Q1 2022, filed 16 May 2022.